The market size of the global bone growth stimulator market in the year 2023 is valued at 1161.47 Million and is predicted to reach 1967.46 Million by the year 2031 at an 7.04 % CAGR during the forecast period.
one growth stimulators are medical devices designed to accelerate recovery in patients undergoing treatments for conditions such as spinal fixation and orthopedic repairs. These devices are used to treat acute fractures, non-unions, and fractures at high risk of delayed healing. Over the forecast period, the global bone growth stimulators market is expected to be driven by increasing demand in emerging economies.
Get A Free Report Brochure:
https://www.insightaceanalytic.com/request-sample/1443
Moreover, the increasing prevalence of bone-related diseases, notably osteoporosis—which is a leading cause of fractures worldwide—is anticipated to bolster the market during the projection period. However, market growth may be restrained by limited reimbursement for bone stimulation products, the high cost of treatments involving BMP and PRP, and adverse effects associated with BMP-based orthopedic therapies.
Market Segmentation:
The bone growth stimulator market is segmented on the product, applications and end-use. Based on product, the market is divided into bone growth stimulation devices, bone morphogenetic proteins and platelet-rich plasma. Based on applications, the bone growth stimulator market is divided into spinal fusion surgeries, delayed union & non-union bone fractures, and oral and maxillofacial surgeries. Based on end-use, the bone growth stimulator market is segmented into hospital & ASCs home care settings, academic & research institutions.
Based on the product, the bone growth stimulation devices segment is a significant contributor to the bone growth stimulator market.
The bone growth stimulation devices segment is estimated to hold a significant market share. The segment’s growth can be due to the growing number of patients undergoing spinal fusion operations worldwide. Furthermore, the rising prevalence of age-related spinal disorders and fractures propels the market. Aging causes bone density to decrease and bones to weaken owing to excessive bone mass loss, which can lead to fractures and spinal issues. Furthermore, the high cost of the treatment and the rising volume of procedures are significant drivers supporting segmental expansion during the forecast period.
Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/1443
The Spinal fusion surgeries segment witnessed growth at a rapid rate.
Spinal fusion surgeries grabbed the highest revenue share, and it is anticipated that they will continue to hold that position during the anticipated time. This considerable market share is primarily due to increasing patient knowledge of the procedural aid provided by bone growth stimulation devices and technological developments. The bone growth stimulation devices have various applications, including spinal fusion procedures, non-union bone fractures, and maxillofacial surgeries.
The North American bone growth stimulator market holds a significant regional revenue share.
The North American bone growth stimulator market is expected to register the highest market share in revenue soon. Because of the increased occurrence of orthopedic and spinal disorders such as bone fractures and spinal injury, better therapeutic techniques and enhanced treatment processes have positively impacted the American market’s expansion. Furthermore, the growing patient population for orthopedic fixation treatments, high awareness among the American public, and high spending income are some of the numerous reasons driving the market in this region’s growth.
Competitive Landscape
Some major key players in the bone growth stimulator market are Orthofix US LLC, Stryker, Medical Device Business Services, Inc., Bioventus, Medtronic, DJO, LLC, Zimmer Biomet, Arthrex, Inc., Terumo Corporation, and Ossatec Benelux BV.
Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/1443
Segmentation of Bone Growth Stimulator Market-
By Product-
- Bone Growth Stimulation Devices
- Bone Morphogenetic Proteins
- Platelet-rich Plasma
By Application
- Spinal Fusion Surgeries
- Delayed Union & Non-Union Bone Fractures
- Oral & Maxillofacial Surgeries
- Other Application
By End-Use
- Hospital & ASCs
- Home Care Settings
- Academic & Research Institutes
By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Get More Information:
https://www.insightaceanalytic.com/report/global-bone-growth-stimulator-market/1443
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
